X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Panacea Biotech Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Quarterly Results   (PANB)

Here are the latest quarterly results of Panacea Biotech. For more details, see the Panacea Biotech financial fact sheet and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Panacea Biotech Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,2371,3721,0221,6701,0761,5261,5221,676 
Other income Rs m11220013774121819127 
Turnover Rs m1,3491,5721,1591,7441,0891,5441,5411,802 
Expenses Rs m1,1291,2691,0241,1931,1491,1571,2191,461 
Gross profit Rs m107103-2102-73369303215 
Depreciation Rs m166166165161144144145138 
Interest Rs m250255263246259265251257 
Profit before tax Rs m-197-118-293-230-463-22-74-53 
Tax Rs m0002517342332 
Profit after tax Rs m-197-118-293-255-480-56-97-86 
Gross profit margin %8.77.5-0.26.1-6.724.219.912.8 
Effective tax rate %0.00.00.0-10.7-3.6-154.8-31.4-60.7 
Net profit margin %-15.9-8.6-28.6-15.3-44.6-3.7-6.4-5.1 
Diluted EPS Rs -3.2 -1.9 -4.8 -4.2 -7.8 -0.9 -1.6 -1.4  
Diluted EPS (TTM) Rs 8.6 9.5 1.9 -14.1 -18.7 -17.7 -14.5 -11.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Panacea Biotech 4QFY18 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   FDC LTD.  DIVIS LABORATORIES  ALEMBIC PHARMA  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  

Compare PANACEA BIOTECH With:   FDC LTD.  DIVIS LABORATORIES  ALEMBIC PHARMA  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Views on news

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 17, 2018 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - ACTAVIS COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS